The mechanisms by which S-nitrosohemoglobin (SNOHb) stimulate vasodilation are unclear and underlie the controversies surrounding the proposal that this S-nitrosothiol modulates blood flow in vivo. Amongst the mechanistic complexities are the nature of vasoactive species released from SNOHb and the role heme and oxygen play in this process. This is important to address since Hemoglobin inhibits NO-dependent vasodilation. We compared the vasodilatory properties of distinct oxidation and ligation states of SNOHb at different oxygen tensions. The results show that SNOHb in the oxygenated state (SNOoxyHb) is significantly less efficient than SNOHb in the ferric or met oxidation state (SNOmetHb) at stimulating relaxation of isolated rat aortic rings.
Introduction
The physiological functions of hemoglobin (Hb) include transport of the respiratory gases oxygen (O 2 ) and carbon dioxide (CO 2 ), and buffering of blood pH 1; 2 . Allosteric regulation of O 2 affinity is a central facet of these processes that allow coordinated delivery of O 2 to respiring tissues and CO 2 to the lungs. More recently, via formation of S-nitrosohemoglobin (SNOHb), these concepts have been extended to include regulation of nitric oxide activity (NO) in the vasculature and have led to the suggestion that Hb can modulate blood flow and other NO-dependent signaling pathways [3] [4] [5] [6] [7] .
Classically, Hb is associated with an inhibition of NO reactivity arising from the rapid rate of reaction between ferrous heme and the nitrogen monoxide radical (•NO; In this text, where discussion refers specifically to the nitrogen monoxide radical the abbreviation •NO will be used. Where discussion refers to a nitric oxide dependent process that maybe mediated by •NO or other redox congeners derived thereof, the abbreviation NO will be used). The reactions that occur between •NO and Hb in the ferrous deoxygenated (deoxyHb or Fe(II)) and ferrous oxygenated (oxyHb or Fe(II)O 2 ) states are shown in equations 1 and 2 and form nitrosylhemoglobin (Fe(II)NO), nitrate and met or ferric hemoglobin (metHb or Fe (III) ) respectively 8 . It is clear that these reactions are important when Hb is outside the confines of the red blood cell and may have a role in mediating vascular dysfunction in sickle cell disease 9- For personal use only. on December 24, 2017. by guest www.bloodjournal.org From 13 . Within the red blood cell however, diffusional constraints provided by the cell membrane and red blood cell free zone created by flow, significantly retard entry of NO into the erythrocyte and hence reaction with Hb 11; 12; 14; 15 . These physical constraints appear to be important in preventing the red blood cell from causing excessive hypertension, although interaction of NO with erythrocytic Hb may still occur as indicated by formation of metHb during NO-inhalation or increased production of NO during inflammation 16 .
Fe(II) + •NO
Alternatively, NO reactions with Hb in vivo have been discussed in the context of mechanisms that preserve and stimulate NO function in the vasculature 4; 7 . Central in this
proposal is the bioactivity of S-nitrosohemoglobin (SNOHb), a derivative in which NO is bound to a specific cysteine residue in the -chain of the protein ( 93Cys). This interaction formally involves the nitrosonium cation (NO + ) bound to the thiolate anion and as such is insensitive to reactions with ferrous heme. It has been suggested that SNOHb elicits NO-dependent vasodilation in environments of low oxygen tension and thereby stimulates blood flow to these regions 4 . Specifically, deoxygenation of SNOHb is followed by transfer of the NO-group, via a transnitrosation reaction to either erythrocytic glutathione (GSH) or thiols on the anion exchange protein (AE-1, also referred to as band 3 protein) 4; 7; 17; 18 . In the case of GSH, the resultant low molecular weight S-nitrosothiol (RSNO), S-nitrosoglutathione (GSNO), is thought to then leave the red blood cell and stimulate NO-signaling in the vasculature. With the anion exchange protein, the corresponding high molecular weight RSNO then transduces the NO-signal out of the red blood cell by undefined mechanisms 19 .
For personal use only. on December 24, 2017. by guest www.bloodjournal.org From However, this model is controversial with many aspects of the proposed mechanism disputed. These include the oxygen dependence and kinetics of SNOHb reactivity with thiols 20 -25 , the mechanisms of SNOHb formation and physiological concentrations of these species in the human arterial and venous circulation 10; 23; 26-29 .
Also, it is unclear how SNOHb in the oxy ferrous state (SNOoxyHb) can elicit •NOdependent signaling in the presence of ferrous heme. To circumvent this problem, it has been suggested that the vasorelaxant stimulus is not •NO per se, but a S-nitrosothiol (e.g.
GSNO)
that is insensitive to reaction with oxyheme 4; 7 . However, it also been argued by the same group that to avoid fatal hypotension a significant portion of the bioactive NO released from SNOHb is autocaptured by ferrous heme 17 . This would however, necessitate the formation of •NO. 
Experimental Procedures

Materials
All reagents were purchased from Sigma Chemical Co. St. Louis, MO. SNOC and SNAP were synthesized as previously reported 22 . DeaNonoate and GSNO was purchased from Alexis Biochemicals. Human HbA was purified as described below.
Preparation of Hemoglobin and S-nitroso-hemoglobin
Human hemoglobin was prepared as previously described and stored as the carbonmonoxy derivative 22 . Briefly, erythrocytes were washed, lysed and Hb purified by ammoniumsulfate precipitation at 4°C, dialyzed versus 3mM sodiumphosphate buffer, pH 7.4 and stored in liquid N 2 . Carbon monoxide was routinely purged through solutions to convert Hb into the carbonmonoxide bound state (to prevent oxidation to metHb).
OxyHb was prepared by photolysis under oxygen at 4°C with no detectable formation of metHb, and had similar oxygen affinities to HPLC-purified Hb (not shown) suggesting organic phosphates are not present in Hb preparations described above. MetHb was prepared by addition of a 1.2-1.4 molar excess of K 3 Fe(CN) 6 to oxyHb and then purified by gel filtration chromatography using Sephadex G-25 (10x1ml, pre-equilibrated with PBS, pH7.4). SNOoxyHb was synthesized by incubating oxyHb (0.2-2mM all stated Hb concentrations are in terms of heme) with SNAP (2-20mM) for 15-30mins at 20°C in 2% borate + 1mM DTPA. For some experiments S-nitrosocysteine (SNOC, 2-20mM) was used instead, and incubations with Hb carried out at 20°C for 5 minutes in 2% borate + 1mM DTPA. For SNOmetHb preparation, metHb was S-nitrosated as described above
For personal use only. on December 24, 2017. by guest www.bloodjournal.org From with oxyHb. All solutions were protected from light. Hb was separated from SNOC or SNAP by gel filtration using Sephadex G-25 (10x1ml, pre-equilibrated with PBS + 1mM DTPA, pH7.4). Using SNAP no significant metHb (measured by visible spectroscopy) was formed in SNOoxyHb preparations. Any preparations of SNOoxyHb that contained metHb (>2-3% determined using the winterbourne equations 34 ) were discarded. OxyHb concentrations were determined by UV-Vis spectroscopy using the extinction coefficient per heme group 577nm =14.6mM -1 cm -1 22 . MetHb concentrations were determined by reduction to deoxyHb using sodium dithionite and S-nitrosation of Hb quantified by the Saville reaction with all mercury dependent nitrite formation being protein precipitable.
SNOHb preparations varying between 0.4 -2 SNO per Hb tetramer were used in this study and are indicated in the figure legends.
Vessel Reactivity Studies.
Isometric tension in isolated rat thoracic aortic ring segments were measured as described previously 35 . Upon sacrifice, the aorta was excised and cleansed of fat and adhering tissue. Vessels were then cut into individual ring segments (2-3 mm in width) and suspended from a force-displacement transducer in a tissue bath. M). In some experiments L-NAME (1mM) was also added to inhibit eNOS and endogenous NO production. This prevents any confounding effects on vascular tone that may occur due to reactions between added Hb and endogenous NO. After tension development reached a plateau, GSH (100µM), SOD (100U/ml) and then NO donors or Hb derivatives were added cumulatively to the vessel bath (as described in Figure   Legends ) and effects on tension monitored. At the end of each experiment, vessel viability was monitored by determining relaxation in response to sodium nitroprusside.
No changes in vessel viability were observed in any of the experimental conditions. Real time data were downloaded to an IBM PC and analyzed using commercially available software. Due to inherent differences in sensitivity of different vessel preparations, relaxation responses to different stimuli (e.g. SNOoxyHb vs SNOmetHb or high vs low oxygen) were compared using vessels obtained from the same preparation and folddifference in the EC 50 s (concentration at which 50% relaxation was observed) calculated.
'n' values correspond to individual experiments conducted using different vessel and SNOHb preparations. Within a given experiment, each condition was repeated 2-4 times.
Low oxygen tension studies
For experiments at low oxygen tensions, a similar protocol described by McMahon et al 17 was followed. Vessel baths were perfused with 5%CO 2 95%N 2 for 15 minutes prior to addition of relaxation stimuli. These studies were performed under "high oxygen"
(perfusion with 95%O 2 , 5%CO 2 ) first, followed by "low oxygen" (perfusion with 95%N 2 ,
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Between each condition, vessels were washed extensively and re-equilibriated for 30 minutes in KH buffer at 37˚C. Oxygen tensions in the vessel baths perfused with 'high' or 'low' oxygen gas mixtures were determined using an oxygen electrode (Instech/YSI).
Oxygen concentrations were calibrated by addition of sodium dithionite to baths perfused with room air (37°C) and set to 195µM O 2 (calculated from oxygen solubility constants at 37°C for Krebs buffer). Perfusion with high oxygen gas increased concentrations to 902µM. Perfusion with low oxygen gas decreased concentrations to 14.5µM. The extent of Hb deoxygenation was determined by measurement of the oxygen binding curve to SNOHb and direct measurement of Hb ligation states using visible spectroscopy. Oxygen binding curves were determined as previously described 22 . The degree of Hb deoxygenation was determined by addition of SNOoxyHb (3µM heme) to the vessel bath perfused with the low oxygen gas mixture. Aliquots of SNOHb were taken using gas tight syringes and transferred to a sealed cuvette in which the gas had been replaced with the 5%N 2 , 95%CO 2 mixture and spectrum (500-700nm) measured. The SNOHb solution was then exposed to room air (to form oxygenated Hb) followed by addition of sodium dithionite (to form fully deoxyHb) and spectra measured.
Statistics All results are reported as the mean ± SEM. Statistical analysis was performed using Origin Software. Differences between the groups were assessed by one-way analysis of variance (ANOVA).
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Results
Effect of heme redox state on SNOHb dependent relaxation
To investigate the mechanisms by which SNOHb elicits NO-dependent signaling, we compared vasodilatory effects of SNOoxyHb and SNOmetHb using isolated rat thoracic aorta. Figure 1A shows representative vessel tension traces measured as a function of time. Aortae were precontracted with both phenylephrine (PE) and the nitric oxide synthase inhibitor, L-NAME which was added to prevent vasoconstriction that occurs due to scavenging of endogenous •NO by added oxyheme. Under these conditions, addition of SNOoxyHb alone, or oxyHb in the presence or absence of GSH had no effect on vessel tone. Consistent with previous reports however 4; 17; 24 , in the presence of GSH, SNOHb stimulated vasorelaxation as indicated by a decrease in vessel tension ( Figure   1A ). Similar data were observed with SNOmetHb, although the kinetics of the relaxation process appeared to be faster with metheme (data not shown). To directly compare the vessel reactivity of SNOHb in the oxyferrous and ferric oxidation states, the efficiency of vessel relaxation mediated by these derivatives was determined. Figure 1B shows that both SNOoxyHb and SNOmetHb stimulate vessel relaxation in a dose dependent manner with SNOoxyHb being 2.2 ± 0.3 fold (mean ± sem, n=8) less efficient at promoting vasodilation compared to SNOmetHb. This is indicated by the right shift in the dose response curve ( Figure 1B ) and determination of the fold difference in EC 50 for relaxation ( Figure 1C ). To determine the heme oxidation and ligation state after stimulation of relaxation, aliquots were taken from the respective vessel baths and UVVisible spectrum monitored. In the case of SNOoxyHb a typical spectrum of oxyHb was obtained that was transformed to the carbonmonoxy derivative upon bubbling of carbon
For personal use only. on December 24, 2017. by guest www.bloodjournal.org From monoxide through the solution ( Figure 1D ). In the case of SNOmetHb, a typical metHb spectrum (at pH7.4) was obtained and was converted to the cyano-ferric complex spectrum upon addition of potassium cyanide ( Figure 1D ). These spectra and associated changes upon addition of selective ferrous and ferric ligands, were identical to those obtained from SNOHb samples prior to the addition to the vessel baths and reactions with GSH. These data indicate that during the course of relaxation, both SNOoxyHb and SNOmetHb remain in their respective oxidation states and still competent to bind ligands.
Furthermore, no formation of the CO derivative was observed upon addition of CO to SNOmetHb indicating that reduction of metHb to ferrous Hb was not occurring during the relaxation response (not shown). In the case of SNOoxyHb therefore, the ferrous heme is still capable of scavenging and inhibiting •NO-dependent vasodilation.
Effect of oxyHb on GSNO, SNOoxyHb and SNOmetHb dependent relaxation
To test for a role of •NO in mediating SNOHb dependent relaxation, the effect of adding oxyHb or oxymyoglobin (oxyMb) to relaxed ring segments was tested. In these experiments contraction induced by addition of oxyheme is consistent with a role for
•NO, similar to that observed when endothelial dependent relaxation is stimulated by acetylcholine or exogenous administration of nitrosovasodilators 36; 37 . These data indicate that SNOoxyHb and SNOmetHb promote vasodilation via different mechanisms. Furthermore, these data also suggest that with cell free SNOoxyHb, GSNO does not play a significant role in the observed vasorelaxant responses.
Effect of SOD on GSNO, SNOoxyHb and SNOmetHb dependent relaxation
To further probe the nature of the NO derivative that mediates SNOHb dependent 
Effect of oxygen on vasodilation mediated by SNOHb
It has been argued that SNOHb mediated relaxation is regulated by the allosteric state of the Hb, with deoxygenation allowing transfer of NO from SNOHb to GSH or Figure 5A ). Consistent with previous findings, a sigmoidal binding curve was obtained with a p50 of 9.3mmHg at 37°C 22 . An oxygen tension of 11.7mmHg would be expected to cause approximately 40% deoxygenation. To determine this directly, SNOHb was transferred using a gas tight syringe into a sealed cuvette in which the gas had been replaced with the 5%N 2 , 95%CO 2 mixture and spectrum (500-700nm) measured (
Figure 5B of Hb, and is consistent with the measured oxygen tensions and oxygen binding curves.
These data demonstrate that an 'R' to 'T' transition within the physiological range is occurring under these experimental conditions. Figure 5C shows representative traces for SNOHb dependent relaxation at high and low oxygen tensions. The left shift in dose response curve at low oxygen tensions demonstrates a more efficient relaxation response.
Similar responses were observed for the other nitrosovasodilators tested. Table 1 shows that for all the NO-donors tested, the EC 50 's for relaxation decreased (i.e. more efficient)
at lower oxygen tensions.
The concentrations of heme in the vessel bath that led to vasodilation were in the nM-µM range. Over these concentrations significant dimerisation of Hb can occur (Kd approximately 3µM heme). This in turn would affect deoxygenation and the 'R' to 'T' transition. To investigate the possible role of dimers, vessel dilation responses at high and low oxygen tensions were measured after addition of SNOoxyHb (0.5SNO per tetramer)
to yield final heme concentrations of 1µM and 10µM respectively. At the latter
For personal use only. on December 24, 2017. by guest www.bloodjournal.org From concentration, tetrameric Hb will be more predominant than dimeric Hb. The relaxation efficiency increased at low oxygen tensions for both 1µM (3.4±1.2% to 16.2 ± 3.4% high versus low oxygen respectively) and 10µM heme (16.9±2.3% to 34.9±7.6% high versus low oxygen respectively). Furthermore, inclusion of inositol hexaphosphate (100µM) which stabilizes the 'T' state and thus reduces dimerisation, had no effect on the relaxation responses at 1µM heme (3.8% to 18.5% at high versus low oxygen tensions respectively). These data demonstrate that vasorelaxant responses at different oxygen tensions do not appear to be modulated by the Hb dimer-tetramer equilibrium.
The effect of oxygen on the mechanisms of SNOHb mediated relaxation was further tested by using SOD. Figure 6 shows that similar to responses at high oxygen, SOD decreased the EC 50 for relaxation mediated by SNOmetHb or GSNO by 3-4 fold under low-oxygen conditions, but had no effect on the responses stimulated by SNOoxyHb.
Potential role of Nitroxyl anion in SNOHb mediated vasodilation.
The data presented above point to a distinct NO-derived vasodilator being produced from In this study we investigated the effect of heme redox state and oxygen on SNOHb mediated vasodilation and the intermediates involved in this process. The increased efficiency by which erythrocytic or cell free SNOHb stimulates vasodilation at low oxygen tensions is a central observation to the proposal that in vivo, deoxygenation of SNOHb is an important regulatory element of its biological function. These data have been reproduced by others and in this study ( Figure 5 and Table 1 ). We have extended these latter observations and show increases in relaxation efficiency for angelis salt, GSNO and the •NO-donor compound (DeaNonoate) at low oxygen. These nitrosovasodilator compounds were chosen for comparison since they are structurally and mechanistically distinct. Furthermore, none of these NO-donor compounds are subject to oxygen dependent allosteric regulation. The increases in efficiency of the relaxation The mechanism by which NO -mediates vascular relaxation appears to be tissue specific with both •NO-independent and dependent processes being reported 48 . Data presented in Figure 7 shows that oxyHb inhibits NO -mediated relaxation suggesting the intermediate formation of a species that reacts with ferrous heme. The identity of this species is not known but is likely to be •NO formed via oxidation of NO -through specific interactions with redox centers in the vessel wall or with oxygen 49 . The data presented in Figure 7 would not favor a role for NO -in the vasodilatory mechanisms of SNOoxyHb. However, it is also becoming apparent that the biological responses to NO -depend on its excited Our data suggest however a thiol dependent, NO-derived vasorelaxant species is released from SNOHb which is not subject to inhibition by oxyheme. The biological impact of this process remains to be defined but may play a role in ability of erythrocytic SNOHb to mediate vasodilation. Physiologically however, the low concentrations compared to the non-S-nitrosated controls 56 . Furthermore, SNOHb is present at significantly higher concentrations (in the µM range) in endotoxemic rats 32 . Coupled with studies showing that Hb can be S-nitrosated by NO derived from the inducible isoform of nitric oxide synthase, a potential role for SNOHb in inflammation is indicated 57 . Data presented in this study indicate that the heme oxidation state, the presence of SOD and thiols will be important determinants of the biological effects of SNOHb administered therapeutically or formed during inflammation.
For 
411.
For SNOHb with defined oxidation states and differing extents of S-nitrosation were added to isolated rat thoracic aorta and effects on tension determined as described in methods.
Panel A shows representative vessel tension traces and demonstrates the ability of SNOoxyHb (1.4SNO per tetramer) to mediate relaxation responses in the presence of glutathione (GSH). Phenylephrine and L-NAME were added to vessel baths as indicated to induce a contraction. Once a steady tension had developed, GSH (100µM) was added followed by different Hb derivatives (1µM in heme final concentration) as indicated.
Addition of SNOoxyHb alone, GSH alone, or oxyHb + GSH had no effect on vessel tone, 
L-
